HANNU RAJANIEMI’S NEW NOVEL DARKOME TO BE PUBLISHED BY GOLLANCZ IN SEPTEMBER!
Hannu Rajaniemi’s new novel, DARKOME, will be published by Gollancz on September 5 2024. Since SUMMERLAND, Hannu has also been building HelixNano, a biotech startup augmenting the immune system’s power to fight disease with mRNA. At the start of the pandemic, he and his team refocused the company’s efforts on COVID. Now they have launched a clinical trial for a next-generation COVID vaccine in designed to generate strong responses in immunosuppressed individuals. (https://www.einpresswire.com/article/697341469/helixnano-s-subsidiary-helixnano-australia-receives-hrec-approval-to-initiate-a-phase-1-clinical-trial). HelixNano is also developing novel cancer vaccines, and has raised ~$70M USD from some of the world’s top investors including Sam Altman, the CEO of OpenAI.
Hannu was already thinking about biology in the context of science fiction as well, but the pandemic experience transformed his thinking, both in his writing, and in what HelixNano is developing. The unique result was DARKOME, a near-future biotech thriller where a young woman discovers how to hack her own — and everyone’s — biology. But such power comes at a cost, and there are those who will stop at nothing to possess her secret.